Northwestern University Feinberg School of Neurology
The Department of Neurology at Northwestern University's Feinberg School of Medicine comprises clinicians, scientists, and clinician-scientists who care for patients, teach medical students, residents, and fellows, and conduct basic, clinical, and translational research. The mission of the department is to provide the highest quality care and treatment for patients with neurological disorders. The department strives to advance new therapies, develop and implement educational programs, and conduct basic and clinical research to uncover the causes and cures of central and peripheral neurologic diseases.

Les Turner ALS Foundation
The Les Turner ALS Foundation is the only local independent publicly supported non-profit organization in the Chicago area devoted solely to the treatment and elimination of amyotrophic lateral sclerosis (ALS), better known as Lou Gehrig's disease. The foundation is affiliated with Northwestern University's Feinberg School of Medicine, Community Health Charities of Illinois and the International Alliance of ALS/MND Associations.

The ALS Foundation
The ALS Association (ALSA) is the only national non-profit health organization dedicated solely to the fight against amyotrophic lateral sclerosis (ALS). ALSA covers all the bases — research, patient and community services, public education and advocacy — in providing help and hope to those people facing the disease. The mission of ALSA is to find a cure for and improve life for those with ALS.

Tri-State Trek
The Tri-State Trek is an incredible three-day bike ride that raises money for ALS/TDF and its fight to end Lou Gehrig's disease. Crossing three states by bicycle on some of the most beautiful and challenging backroads in New England, advocates and volunteers raise money and awareness to promote the benefits of stem cell research as an end to neuromuscular diseases.

ALS Therapy Development Institute
The ALS Therapy Development Institute is a non-profit biotechnology company discovering treatments for patients alive today. Their approach combines the power of a non-profit mission with the best practices of a for-profit biotechnology company: rigorous, open-minded research and proven drug development techniques.